Evidence for a multiclonal origin of multicentric advanced lesions of kaposi sarcoma

Journal of the National Cancer Institute

Volumn 99, Issue 14, 2007, Pages 1086-1094

  Duprez, Renan ^a   Lacoste, Vincent ^a   Brière, Josette ^b   Couppié, Pierre ^c   Frances, Camille ^d   Sainte Marie, Dominique ^c   Kassa Kelembho, Eric ^e   Lando, Marie Jeanne ^f   Oyono, Jean Louis Essame ^g   Nkegoum, Blaise ^f   Hbid, Oumkaltoum ^h   Mahé, Antoine ⁱ   Lebbé, Céleste ^b   Tortevoye, Patricia ^a   Huerre, Michel ^a   Gessain, Antoine ^a  

^a INSTITUT PASTEUR   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Institut Pasteur de Cayenne   (French Guiana)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^f Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

^g CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^h Institut Pasteur du Maroc   (Morocco)

ⁱ Institut dHygiene Sociale Dakar   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; GENOMIC DNA; HEMATOXYLIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CELL INFILTRATION; CELL PROLIFERATION; CLONAL VARIATION; DISEASE ASSOCIATION; DISSEMINATED CANCER; DNA PROBE; DNA SEQUENCE; ELECTROPHORESIS; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; LONG TERMINAL REPEAT; LYMPH NODE BIOPSY; MALE; METASTASIS POTENTIAL; MULTIPLE CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; SPINDLE CELL; STAINING; TONSIL; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLONE CELLS; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SKIN; VIRAL LOAD;

EID: 34547818237     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm045     Document Type: Article

References (44)

1. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003;67:175-212.
2. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002;2:281-92.
3. Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, Heiden T, Biberfeld P. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int J Cancer 2006;119:1262-7.
4. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
5. Dorfman RF. Kaposi's sarcoma revisited. Hum Pathol 1984;15:1013-7.
6. Enzinger F, Weiss S. Soft tissue tumors. 3rd ed. St Louis (MO): Mosby Co; 1995. p. 658-69.
7. Gessain A, Duprez R. Spindle cells and their role in Kaposi's sarcoma. Int J Biochem Cell Biol 2005;37:2457-65.
8. Rosai J. Kaposi sarcoma. In: Ackerman's surgical pathology. 8th ed. St Louis (MO): C.V. Mosby; 1996. p. 184-8.
9. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol Mech Dis 2006;1:273-96.
10. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995;1:1274-8.
11. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identifi cation of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
12. Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am 2003;17:717-45.
13. Wong EL, Damania B. Linking KSHV to human cancer. Curr Oncol Rep 2005;7:349-56.
14. Schulz TF. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 2006;208:187-98.
15. Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. Kaposi's sarcoma-associated herpesvirus immune modulation: An overview. J Gen Virol 2006;87(pt 7):1781-804.
16. Davis MA, Sturzl MA, Blasig C, Schreier A, Guo HG, Reitz M, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997;89:1868-74.
17. Fialkow PJ. Clonal origin of human tumors. Biochim Biophys Acta 1976;458:283-321.
18. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985;227:642-5.
19. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997;50:664-8.
20. Diaz-Cano SJ, Wolfe HJ. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:571-2.
21. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:570-1; author reply 571-2.
22. Gill PS, Tsai YC, Rao AP, Spruck CH 3rd, Zheng T, Harrington WA Jr, et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 1998;95:8257-61.
23. Rabkin CS, Bedi G, Musaba E, Sunkutu R, Mwansa N, Sidransky D, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995;1:257-60.
24. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
25. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-7.
26. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodefi ciency syndrome-associated lymphoma. Blood 1991;77:1092-5.
27. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
28. Judde JG, Lacoste V, Briere J, Kassa-Kelembho E, Clyti E, Couppie P, et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst 2000;92:729-36.
29. Hbid O, Belloul L, Fajali N, Ismaili N, Duprez R, Tanguy M, et al. Kaposi's sarcoma in Morocco: A pathological study with immunostaining for human herpesvirus-8 LNA-1. Pathology 2005; 37:288-95.
30. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multi-centric castleman disease in HIV-infected patients. Blood 2000; 96:2069-73.
31. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, et al. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 2002;102:37-51.
32. Wang Z, Chang SY, MacMullen G, Huang D, Kwok S, Spadoro J. Use of internal control quantitative standards to quantify target nucleic acid sequences by PCR, poster abstract. In: Program and abstracts of the San Diego Conference: The genetic revolution. Washington (DC): American Society for Clinical Chemistry; 1994. p. 12.
33. Boulanger E, Duprez R, Delabesse E, Gabarre J, Macintyre E, Gessain A. Mono/oligoclonal pattern of Kaposi sarcoma-associated herpesvirus (KSHV/ HHV-8) episomes in primary effusion lymphoma cells. Int J Cancer 2005;115:511-8.
34. Perez A, Sanchez JL, Almodovar PI. Kaposi's sarcoma is not a neoplasm let alone a sarcoma. Int J Dermatol 2003;42:844-5.
35. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001;356:517-34.
36. Aboulafia DM. Regression of acquired immunodefi ciency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin Proc 1998;73:439-43.
37. Barete S, Calvez V, Mouquet C, Barrou B, Kreis H, Dantal J, et al. Clinical features and contribution of virological fi ndings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol 2000;136:1452-8.
38. Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, et al. Immune reconstitution infl ammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005;23:5224-8.
39. Stebbing J, Portsmouth S, Gazzard B. How does HAART lead to the resolution of Kaposi's sarcoma?. J Antimicrob Chemother 2003;51:1095-8.
40. Grundhoff A, Ganem D. Ineffi cient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 2004;113:124-36.
41. Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, et al. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer 1995;75:2747-56.
42. Walling DM, Andritsos LA, Etienne W, Payne DA, Aronson JF, Flaitz CM, et al. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease. J Med Virol 2004;74:94-101.
43. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of post-transplantation lymphoproliferative disorders. Semin Diagn Pathol 1997;14:15-26.
44. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodefi ciency virus HIV-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 2003;27:293-302.